Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio A Rodriguez

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Microbial Cell Factories|May 2, 2021
Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirusNeil C Dalvie, Joseph R Brady, Laura E Crowell, et al.
Science Advances|December 8, 2021
Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2Kristen A Rodrigues, Sergio A Rodriguez-Aponte, Neil C Dalvie, et al.
Science Translational Medicine|July 20, 2022
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunityBrittany L Hartwell, Mariane B Melo, Peng Xiao, et al.
Msphere|August 15, 2022
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC ChallengeTing Y Wong, Brynnan P Russ, Katherine S Lee, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
Biorxiv : the Preprint Server for Biology|July 20, 2021
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primatesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Science Advances|March 16, 2022
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaquesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Microbial Cell Factories|May 2, 2021
Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirusNeil C Dalvie, Joseph R Brady, Laura E Crowell, et al.
Science Advances|December 8, 2021
Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2Kristen A Rodrigues, Sergio A Rodriguez-Aponte, Neil C Dalvie, et al.
Science Translational Medicine|July 20, 2022
Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunityBrittany L Hartwell, Mariane B Melo, Peng Xiao, et al.
Msphere|August 15, 2022
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC ChallengeTing Y Wong, Brynnan P Russ, Katherine S Lee, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
Biorxiv : the Preprint Server for Biology|July 20, 2021
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primatesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Science Advances|March 16, 2022
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaquesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Pageof 4